#MetaplasticBreastCancer

Neoadjuvant chemo-immunotherapy response predicts long-term survival

KEYNOTE-522
N=32 stage I-III

high stromal tumor-infiltrating lymphocytes corr. pCR
pCR (n=7)➡️no recurrence
2/3 of residual disease➡️recurrence in 14 mo

#NPJBreastCancer2025
www.nature.com/articles/s41...